Lv4
750 积分 2023-09-05 加入
Moving towards a new era for the treatment of neuromyelitis optica spectrum disorders
2天前
已完结
Prevalence of Progression Independent of Relapse Activity and Relapse-Associated Worsening in Patients With AQP4-IgG–Positive NMOSD
2天前
已完结
Relapse-Independent Disease Activity in Neuromyelitis Optica Spectrum Disorder: A Systematic Review
2天前
已完结
Update on diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) — recommendations of Section of Multiple Sclerosis and Neuroimmunology of Polish Neurological Society
2天前
已完结
Therapeutic Approach to Autoimmune Neurologic Disorders
2天前
已完结
Factors for Rituximab Refractoriness in AQP4‐IgG+ NMOSD: A Cohort Study
2天前
已完结
Disease-modifying treatments for neuromyelitis optica spectrum disorder in the context of a new generation of biotherapies
2天前
已完结
Imaging Approach to Myelopathies
2天前
已完结
Application and interpretation of core elements of the 2015 NMOSD diagnostic criteria in routine clinical practice
2天前
已完结
Emerging immune tolerance therapies for neuromyelitis optica spectrum disorder
2天前
已完结
皖公网安备34019202002308
